These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21216671)

  • 1. Selective serotonin-reuptake inhibitors and recovery after stroke.
    Robinson RG; Adams HP
    Lancet Neurol; 2011 Feb; 10(2):110-1. PubMed ID: 21216671
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective Serotonin Reuptake Inhibitors for Stroke Recovery.
    Legg LA; Tilney R; Hsieh CF; Wu S; Lundström E; Rudberg AS; Kutlubaev MA; Dennis M; Soleimani B; Barugh A; Hackett ML; Hankey GJ; Mead GE
    Stroke; 2020 Aug; 51(8):e142-e143. PubMed ID: 32552532
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluoxetine and motor recovery after ischaemic stroke.
    Gonzenbach RR; Taegtmeyer AB; Luft A; Russmann S
    Lancet Neurol; 2011 Jun; 10(6):499-500; author reply 500-1. PubMed ID: 21601158
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluoxetine and motor recovery after ischaemic stroke.
    Gaillard R; Mir O
    Lancet Neurol; 2011 Jun; 10(6):499; author reply 500-1. PubMed ID: 21601157
    [No Abstract]   [Full Text] [Related]  

  • 5. BDNF: a possible explanation of findings from the FLAME trial.
    Budhdeo S; Deluca G
    Int J Stroke; 2012 Aug; 7(6):E2. PubMed ID: 22805577
    [No Abstract]   [Full Text] [Related]  

  • 6. Imaging stroke recovery: lessons from Prozac.
    Detre JA
    Ann Neurol; 2001 Dec; 50(6):697-8. PubMed ID: 11761466
    [No Abstract]   [Full Text] [Related]  

  • 7. MAMBO: Measuring ambulation, motor, and behavioral outcomes with post-stroke fluoxetine in Tanzania: Protocol of a phase II clinical trial.
    Vogel AC; Okeng'o K; Chiwanga F; Ismail SS; Buma D; Pothier L; Mateen FJ
    J Neurol Sci; 2020 Jan; 408():116563. PubMed ID: 31731111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
    Legg LA; Tilney R; Hsieh CF; Wu S; Lundström E; Rudberg AS; Kutlubaev MA; Dennis M; Soleimani B; Barugh A; Hackett ML; Hankey GJ; Mead GE
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31769878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time for the next stage of stroke recovery trials.
    Kwakkel G; Meskers CGM; Ward NS
    Lancet Neurol; 2020 Aug; 19(8):636-637. PubMed ID: 32702322
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroplasticity and behavioral effects of fluoxetine after experimental stroke.
    Sun Y; Sun X; Qu H; Zhao S; Xiao T; Zhao C
    Restor Neurol Neurosci; 2017; 35(5):457-468. PubMed ID: 28854520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Listening to fluoxetine: a hot message from the FLAME trial of poststroke motor recovery.
    Cramer SC
    Int J Stroke; 2011 Aug; 6(4):315-6. PubMed ID: 21745341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More evidence that fluoxetine does not improve functional recovery from stroke.
    Drug Ther Bull; 2021 Jun; 59(6):83. PubMed ID: 33741603
    [No Abstract]   [Full Text] [Related]  

  • 13. Can selective serotonin reuptake inhibitors (SSRI) improve motor recovery after stroke? What is the role of neuroplasticity?
    Majeed F; Kamal AK
    J Pak Med Assoc; 2011 Nov; 61(11):1147-8. PubMed ID: 22126003
    [No Abstract]   [Full Text] [Related]  

  • 14. SSRIs in pregnancy--are they safe?
    Koren G
    Pediatr Res; 2002 Apr; 51(4):424-5. PubMed ID: 11919325
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of Fluoxetine on Outcomes at 12 Months After Acute Stroke: Results From EFFECTS, a Randomized Controlled Trial.
    Lundström E; Isaksson E; Greilert Norin N; Näsman P; Wester P; Mårtensson B; Norrving B; Wallén H; Borg J; Hankey GJ; Hackett ML; Mead GE; Dennis MS; Sunnerhagen KS
    Stroke; 2021 Oct; 52(10):3082-3087. PubMed ID: 34465201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitors for stroke recovery.
    Mead GE; Hsieh CF; Hackett M
    JAMA; 2013 Sep; 310(10):1066-7. PubMed ID: 24026602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin Selective Reuptake Inhibitors (SSRIs) and Stroke.
    Chollet F; Rigal J; Marque P; Barbieux-Guillot M; Raposo N; Fabry V; Albucher JF; Pariente J; Loubinoux I
    Curr Neurol Neurosci Rep; 2018 Oct; 18(12):100. PubMed ID: 30353288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The age-dependent effects of selective serotonin reuptake inhibitors in humans and rodents: A review.
    Olivier JD; Blom T; Arentsen T; Homberg JR
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(6):1400-8. PubMed ID: 20883714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Enantiomers: a new problem in pharmacotherapy of depression?].
    Grodner B; Sitkiewicz D
    Psychiatr Pol; 2013; 47(3):511-8. PubMed ID: 23885544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Role of Selective Serotonin Reuptake Inhibitors in Improving Functional Outcome after Stroke.
    Mortensen JK; Andersen G
    CNS Drugs; 2018 Oct; 32(10):895-903. PubMed ID: 30225777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.